EUVIMEDEUVIMED entdecken
Open Access

Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models

Ewa A Ziółkowska iD, Matthew J Jansen iD, Letitia L Williams iD, Sophie H Wang, Elizabeth M Eultgen, Keigo Takahashi iD, Steven Q Le iD, Hemanth R Nelvagal iD, Jaiprakash Sharma iD, Marco Sardiello, Brian J DeBosch iD, Patricia I Dickson iD und 10 weitere

Science Translational Medicine · 2025

DOI: 10.1126/scitranslmed.adj1445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Ewa A Ziółkowska und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Lysosomal Storage Diseases, Genetic Therapy, Nerve Degeneration, Neurons. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children with neurodegenerative disease often have debilitating gastrointestinal symptoms. We hypothesized that this may be due at least in part to underappreciated degeneration of neurons in the enteric nervous system (ENS), the master regulator of bowel function. To test this hypothesis, we evaluated mouse models of neuronal ceroid lipofuscinosis type 1 and 2 (CLN1 and CLN2 disease, respectively), neurodegenerative lysosomal storage disorders caused by deficiencies in palmitoyl protein thioesterase-1 and tripeptidyl peptidase-1, respectively. Both mouse lines displayed slow bowel transit in vivo that worsened with age. Although the ENS appeared to develop normally in these mice, there was a progressive and profound loss of myenteric plexus neurons accompanied by changes in enteric glia in adult mice. Similar pathology was evident in colon autopsy material from a child with CLN1 disease. Neonatal administration of adeno-associated virus–mediated gene therapy prevented bowel transit defects, ameliorated loss of enteric neurons, and extended survival in mice. Treatment after weaning was less effective than treating neonatally but still extended the lifespan of CLN1 disease mice. These data provide proof-of-principle evidence of ENS degeneration in two lysosomal storage diseases and suggest that gene therapy can ameliorate ENS disease, also improving survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lysosomal Storage DiseasesGenetic TherapyNerve DegenerationNeuronsEnteric Nervous SystemGastrointestinal MotilityAnimalsDisease Models, AnimalMiceDipeptidyl-Peptidases and Tripeptidyl-PeptidasesNeuronal Ceroid-LipofuscinosesTripeptidyl-Peptidase 1HumansThiolester HydrolasesAminopeptidasesDependovirus

Substanzen

Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesTripeptidyl-Peptidase 1Tpp1 protein, mouseThiolester HydrolasesAminopeptidases

Autor:innen und Institutionen

  • Department of Pediatrics, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA.
  • Department of Genetics, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA.
  • Children's Hospital of Philadelphia Research Institute and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Batten Disease Support, Research and Advocacy Foundation (US), P.O. Box 30049, Gahanna, OH 43230, USA.
  • Batten Disease Support and Research Association (Australia), 74 McLachlan Avenue, Shelly Beach, NSW 2261, Australia.
  • Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.

ORCID-Profile: Ewa A Ziółkowska, Matthew J Jansen, Letitia L Williams, Keigo Takahashi, Steven Q Le, Hemanth R Nelvagal, Jaiprakash Sharma, Brian J DeBosch, Patricia I Dickson, Jessica B Anderson, Christina M Wright, Rebecca P Bradley, Ineka T Whiteman, Takako Makita, John R Grider, Robert O Heuckeroth, Jonathan D Cooper

Förderung

  • NIDDK NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Ziółkowska, E. A., Jansen, M. J., Williams, L. L., Wang, S. H., Eultgen, E. M., Takahashi, K., Le, S. Q., Nelvagal, H. R., Sharma, J., Sardiello, M., DeBosch, B. J., Dickson, P. I., Anderson, J. B., Sax, S. E., Wright, C. M., Bradley, R. P., Whiteman, I. T., Makita, T., Grider, J. R., …, & Cooper, J. D. (2025). Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adj1445

Vancouver

Ziółkowska EA, Jansen MJ, Williams LL, Wang SH, Eultgen EM, Takahashi K, et al. Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.adj1445

BibTeX
@article{Zikowska2025,
  author = {Ziółkowska, Ewa A and Jansen, Matthew J and Williams, Letitia L and Wang, Sophie H and Eultgen, Elizabeth M and Takahashi, Keigo and Le, Steven Q and Nelvagal, Hemanth R and Sharma, Jaiprakash and Sardiello, Marco and DeBosch, Brian J and Dickson, Patricia I and Anderson, Jessica B and Sax, Sophie E and Wright, Christina M and Bradley, Rebecca P and Whiteman, Ineka T and Makita, Takako and Grider, John R and Sands, Mark S and Heuckeroth, Robert O and Cooper, Jonathan D},
  title = {Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models},
  journal = {Science Translational Medicine},
  year = {2025},
  doi = {10.1126/scitranslmed.adj1445}
}
Kostenlos starten →